3MICROBEADS
Microbead Technology: The Future of Nootropic Delivery Systems
2 min read
**
Essentials
- Encapsulation, involving the creation of small microbeads from powders or granules, offers improved efficacy, controlled release, and the ability to mask unpleasant tastes and odors.*
- Microbead technology in nootropics allows for targeted and sustained release, facilitating nutrient synergy and enhancing absorption.*
Back in the day, tablets were the go-to for every nootropic brand under the sun. And they were good... for the most part. But some found them hard to swallow, unpalatable, unexciting, or just plain dull.
The main issue, however, was their low bioavailability (a fancy term for ‘absorption rate’). This often meant high doses, frequent intake, and slow onset of action, leading to what's known as 'pill fatigue.'*
It's why so many would simply stop taking them, leading to potentially poorer health outcomes.
Challenging tradition.
There has to be a better way of designing these tablets, right? The industry had to look into alternative delivery systems—soft gels, gel caps, capsules, chews, shots, sprinkles, and gummies... all these were a step up from the basic tablet. More efficient when compared to your classic 'horse pill.'*
They offered improved efficacy, faster onset of action, and lower doses. More convenient. More appealing. And more accessible than ever before.*
But despite all these innovations in delivery-system design, formats such as classic capsules and tablets remain the most popular nootropic delivery systems.
Why we believe microbeads are the future of nootropics.
First, it's the most promising, exciting, and overall premium technology in the nootropics sector, by our estimates.
What is encapsulation, exactly?
Well, it's a pretty amazing process. We take tiny particles (often powders or granules), and aggregate them into spherical beads (we call them ‘microbeads’) that can be then coated or encapsulated.
This technique can enhance the efficacy of our nootropics by often modifying the release time of active nutrients. It offers flexibility in formulation. It makes it possible to combine nutrients that may otherwise be incompatible. And it can improve oral delivery.*
Microbeads may also improve the absorption and distribution of active nutrients. Plus, the coating can help mask unpleasant tastes and odors (like, let's say, the fish oil smell not everyone is a fan of).*
What was sci-fi some years ago is entirely possible today
The integration of microbead technology in nootropics marks a pivotal advance in cognitive enhancement products:*
- Targeted-Release: Microbeads can release active nutrients at carefully selected locations (like in the stomach, or in the small intestine), potentially enhancing absorption.*
- Time-Release: Depending on the nootropic, just a single dosage can often be enough to support cognitive enhancement throughout the day, eliminating the need for multiple doses.*
- Nutrient Blends: We can more easily and effectively combine different nutrients in one bead for synergistic effects and stability.
Is this the future of nootropic delivery systems? We believe it is. It promises not only enhanced delivery and absorption of existing nootropics but also fosters the development of new, sophisticated compounds.
As this technology continues to evolve, it is set to transform cognitive enhancement, making it more personalized, effective, and user-friendly as HCF® intends to lead the way.*
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. The contents of this website do not constitute advice and are provided for informational purposes only. See our full medical disclaimer
Meet Our Experts

Conor Sheehy PharmD, BCPS, CACP
Author, Linkedin
Author, Linkedin
Dr. Sheehy earned a BS in Molecular Biology from the University of Idaho and a Doctor of Pharmacy (PharmD) from the University of Washington. He is a Board-Certified Pharmacotherapy Specialist (BCPS) and a Certified Anticoagulation Care Provider (CACP). As a member of the American Medical Writers Association, the College of Psychiatric and Neurological Pharmacists (CPNP), and the National Alliance on Mental Illness (NAMI), his focus has been on innovative dosage deliverability strategies that primarily benefit individuals facing mental health challenges.